. Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong disease-free and overall survival in patients with non small cell lung cancer (NSCLC) responsive to chemotherapy. J Clin Oncol 2005: 23, 234s (supplement), abstract #3171.